News About: Pharm. Industry
Korean drugs increase share in gastritis drug market
Korean-made gastritis drugs accounted for a larger portion of the sector's domestic sales last year, an industry report showed recently.
According to Yakup.com, an information company, Dong-A Pharmaceutical's Stil...
Korea's big firms urged to promote pharmaceutical industry
The government unveiled an ambitious vision in 2010 to foster global pharmaceutical firms through the creation of a large-scale R&D fund and offering various tax benefits to local companies.
At that time the Minist...
Drugmakers, government face off over drug price cuts
Tension is escalating between local pharmaceutical firms and the Ministry of Health and Welfare over the government’s plan to slash drug prices.
So far, the local pharmaceutical industry has raised their voice agai...
Anterogen’s stem cell-based anal fistula drug gets green light from KFDA
The Korea Food and Drug Administration said Thursday that it has approved Cupistem, a stem cell-based anal fistula drug by Anterogen Co., a subsidy of Bukwang Pharmaceutical Co.
Anterogen’s Cupistem is a stem cell ...
Dong-A likely to commercialize new second-generation oxazolidinone antibiotic
Dong-A Pharmaceutical Co. announced Thursday the positive results of its new second-generation oxazolidinone antibiotic (tedizolid phosphate; DA-7218) from the first Phase 3 clinical trial in acute bacterial skin and ...
UCB Korea holds Vimpat symposium
Scores of neurologists and pediatricians at home and abroad gathered in Seoul and Busan between January 13 and 14 to participate in a launching symposium of Vimpat (lacosamide) on the future strategy of epilepsy.
T...
Pharmacists seeking reclassification of some OTC products
A lawyer for five local pharmacists associations, who filed a suit against the Korea Food and Drug Administration, asked to reclassify ointments and patches among 48 non-prescription remedies as quasi-drugs noticed in...
Daewoong to launch oxybutynin gel in Korea
Daewoong Pharmaceutical announced Wednesday that it signed an exclusive licensing agreement with the U.S. based Antares Pharma to distribute Antares’s topical oxybutynin gel 3% product inn Korea.
Last December, The...
Layouts of 1,321 OTC ads approved in 2011
The Korea Pharmaceutical Manufacturers Association said yesterday that it screened a total of 1,351 advertisement layouts on OTC drugs in 2011, up 19.3 percent compared with 1,132 layouts in 2010.
Of the 1,351 lay...
Dong-A to receive additional royalty payments over biosimilar drug
Dong-A Pharmaceutical Co. is expected to receive additional royalty of its biosimilar drug (Japanese code name: FSK-0808) to treat neutropenia from its partner Gene Techno Science (GTS) in Japan.
GTC’s sublicensees...
